parthenolide and Experimental Hepatoma

parthenolide has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, Y; Inoue, H; Nakai, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A; Shiba, M; Takayama, H1

Other Studies

1 other study(ies) available for parthenolide and Experimental Hepatoma

ArticleYear
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
    International journal of cancer, 2007, Jun-15, Volume: 120, Issue:12

    Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Interleukin-8; Lactones; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; NF-kappa B; Phosphorylation; Sesquiterpenes; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2007